OnKure Therapeutics has lined up $60 million in a new private funding round, adding to the Boulder, CO, biotech’s bank account as it works through a Phase II trial. The startup is attempting to create an inhibitor of histone deacetylases, or HDACs, which are DNA-manipulating enzymes that alter how genes…
News
Labor Induction Not Linked to Higher Cesarean Rates in Midwife-Led Births
The Takeaway: A retrospective review of more than 7,300 midwife attended births in three Colorado hospitals found that labor induction did not increase the likelihood of cesarean birth compared to expectant management. Researchers from the […]
News
CSU Releases Findings of Three-Year Research Study on NAVA’S Lakehouse Community
Colorado’s first WELL-Certified residential community showed 36 statistically significant physical, social and emotional benefits of wellness-focused design and operations DENVER, July 10, 2023 /PRNewswire/ — NAVA Real Estate Development (NAVA), in partnership with Colorado State… […]
News
Weekly Policy Blog: HELP Copays Act (H.R. 830)
On February 6, 2023, the federal Help Ensure Lower Patient (HELP) Copays Act (H.R. 830) was reintroduced in the U.S. House of Representatives by Representative Earl “Buddy” Carter (R-GA) and referred to the House Committee on […]
